CHILDREN'S DIMETAPP NIGHTTIME COLD & CONGESTION OTC
Generic Name and Formulations:
Diphenhydramine HCl 6.25mg, phenylephrine HCl 2.5mg; per 5mL; syrup; grape-flavor; alcohol-free; contains sodium 4mg/5mL.
Pfizer Consumer Healthcare
Indications for CHILDREN'S DIMETAPP NIGHTTIME COLD & CONGESTION:
Nasal congestion, rhinorrhea, allergy symptoms.
20mL every 4 hours; max 6 doses/24 hours.
<6yrs: do not use. 6–11yrs: 10mL every 4 hours; max 6 doses/24 hours.
Children <6yrs old. During or within 14 days of MAOIs. Concomitant other diphenhydramine products (including topicals). For use as a sedative hypnotic.
Cardiovascular disease. Hypertension. Thyroid disease. Diabetes. GI or GU obstruction. Glaucoma. Asthma. Lower respiratory disorders. Pregnancy. Nursing mothers.
Antihistamine + sympathomimetic.
See Contraindications. Hypertensive crisis with MAOIs. β-blockers may increase pressor effects of sympathomimetics. Antihypertensives antagonized. Avoid alcohol. Increased CNS effects with other CNS depressants.
Drowsiness, anticholinergic effects, nervousness, dizziness, insomnia, excitability in children.
Syrup—4oz (w. dosing cup)
Renal and Urology News Articles
- Clinicians Somewhat Favor Shared Decision-Making in Older mCRPC Patients
- Higher Push-Up Capacity Linked to Lower Incidence of CVD Events
- Pembrolizumab Shows Promise for BCG-Unresponsive Bladder Cancer
- Radical Cystectomy Superior to Trimodal Therapy for Muscle-Invasive Bladder Cancer
- Dialysis and Transplant Patients at Increased Risk for Cancer Death
Sign Up for Free e-newsletters
NEPHROLOGY & UROLOGY NEWS
- Acute Kidney Injury (AKI)
- Chronic Kidney Disease (CKD)
- Contrast Nephropathy
- Cardiovascular Disease (CVD)
- Diabetic Nephropathy
- End-stage Renal Disease (ESRD)
- Lupus Nephritis
- Peritoneal Dialysis
- Secondary Hyperparathyroidism (SHPT)